Arcadia Biosciences (RKDA) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2016 Financial Results and Business Highlights
March 8, 2017 4:05 PM ESTDAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhancing human health, today released its financial and business results for the fourth quarter and full year of 2016.
The companys loss from operations was $5.5 million in the fourth quarter and $18.6 million for the full year of 2016 compared to $4.1 million in the fourth quarter and $15.6 million for 2015. Net loss attributable to common stockholders in the fourth quarter and full year of 2016 was $5.7 million and $19.6 million, compared to $3.9 million and $20.7 million for... More
